Evidence map›Paper›PMID 38033659›Full record

ArticleCurrent research in toxicology2023

Early diagnostic biomarkers for acute kidney injury using cisplatin-induced nephrotoxicity in rat model.

Sahadeb Jana, Palash Mitra, Ananya Dutta, Amina Khatun, Tridip Kumar Das, Shrabani Pradhan, Dilip Kumar Nandi, Suchismita Roy

Abstract read
In one paragraph

Article in Current research in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Protective effects ofVeterinary world · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The extract of zedoary-turmeric protects rats' kidneys from damage caused by cisplatin.Journal of advanced veterinary and animal research · 2025
    Article
  16. Phytochemicals from Purwoceng (International journal of molecular sciences · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sahadeb JanaBiodiversity and Environmental Studies Research Center, Midnapore City College, Kuturiya, Bhadutala, Midnapore, Paschim Medinipur, Pin- 721129, West Bengal, India.
Palash MitraNutrition Research Laboratory, Department of Paramedical and Allied Health Sciences, Midnapore City College, Midnapore, Paschim Medinipur, Pin-721129, West Bengal, India.
Ananya DuttaBiodiversity and Environmental Studies Research Center, Midnapore City College, Kuturiya, Bhadutala, Midnapore, Paschim Medinipur, Pin- 721129, West Bengal, India.
Amina KhatunBiodiversity and Environmental Studies Research Center, Midnapore City College, Kuturiya, Bhadutala, Midnapore, Paschim Medinipur, Pin- 721129, West Bengal, India.
Tridip Kumar DasBiodiversity and Environmental Studies Research Center, Midnapore City College, Kuturiya, Bhadutala, Midnapore, Paschim Medinipur, Pin- 721129, West Bengal, India.
Shrabani PradhanNutrition Research Laboratory, Department of Paramedical and Allied Health Sciences, Midnapore City College, Midnapore, Paschim Medinipur, Pin-721129, West Bengal, India.
Dilip Kumar NandiNutrition Research Laboratory, Department of Paramedical and Allied Health Sciences, Midnapore City College, Midnapore, Paschim Medinipur, Pin-721129, West Bengal, India.
Suchismita RoyNutrition Research Laboratory, Department of Paramedical and Allied Health Sciences, Midnapore City College, Midnapore, Paschim Medinipur, Pin-721129, West Bengal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney diseases (CKD) caused by acute kidney injury (AKI) results rapid and reversible loss in renal function. A real-time, highly accurate, and sensitive acute kidney injury biomarker is urgently required in order to keep these patients alive and prevent end stage renal disease and related complications that include hypertension, fluid and electrolyte retention, metabolic acidosis, anemia, stroke etc. This study was designed to develop a specific and sensitive model for the early identification of renal damage in male albino rats. Using a single intraperitoneal dose of cisplatin (10 mg/kg body weight) to the rats, the various duration-dependent nephrotoxic activities were compared using multiple physiological, biochemical, genomic, and histopathological markers. We looked into when renal dysfunction would start occurring after receiving a single high dose of cisplatin while blood urea nitrogen (BUN) and serum creatinine (sCr) remained normal. Following a single cisplatin injection, various measurements were taken in plasma, urine, and/or kidney tissues of rats euthanized on days 1, 2, 3, 5, and 7. When the urine kidney injury molecule (KIM-1), interleukine 18 (IL-18), nephrin, neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C (Cys C) levels are greatly raised on day 3 after cisplatin treatment, BUN and sCr levels remain normal. Nephrotoxicity of cisplatin is also indicated by the upregulated mRNA expression of KIM-1, IL-18, Cys C, and NGAL and downregulated expression of nephrin in kidney tissue at very initial stage. Protein expression of KIM-1, IL-18 and NGAL level of kidney tissues was upregulated indicated confirmatory results done by western blot. Utilising an array of kidney impairment indicators has emerged as an earlier, more effective, and more reliable technique to diagnose AKI when compared to the most sophisticated signs now available.

Indexed as

Acute Kidney InjuryCisplatinKIM-1NephrinNGALRenal dysfunction

Identifiers

PMID38033659
PMCPMC10682538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.